Alcon ALC
NYSE ALC
$66.03 -0.52 (-0.78%)
As of: Sep 11, 2026 · 3:59 PM EDT

Alcon (ALC) Accumulated Expenses (2009 - 2010)

Alcon (ALC) posted Accumulated Expenses of $339.0 million for Q4 2010, up 6.27% on a QoQ basis from $319.0 million in Q3 2010, and up 1.8% year-over-year from $333.0 million in Q4 2009.

Analysis

Alcon (ALC) Accumulated Expenses (2009 - 2010) Analysis & Trends

Alcon has reported Accumulated Expenses for 2 years, with the latest figure at $339.0 million in Q4 2010.

  • On a quarterly basis, Accumulated Expenses rose 1.8% year-over-year to $339.0 million in Q4 2010; TTM through Dec 2010 was $339.0 million, a 1.8% increase from a year earlier, with the FY2010 full-year figure at $339.0 million, up 1.8% from the prior year.
  • Accumulated Expenses was $339.0 million for Q4 2010 at Alcon, up from $319.0 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $339.0 million in Q4 2010, with the low at $290.0 million in Q2 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.00 Bn 17.59 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 339.00 Mn
Sep 30, 2010 319.00 Mn
Jun 30, 2010 290.00 Mn
Dec 31, 2009 333.00 Mn